CN102884048A - 用作hcn阻滞剂的氨基杂芳基衍生物 - Google Patents
用作hcn阻滞剂的氨基杂芳基衍生物 Download PDFInfo
- Publication number
- CN102884048A CN102884048A CN2010800645209A CN201080064520A CN102884048A CN 102884048 A CN102884048 A CN 102884048A CN 2010800645209 A CN2010800645209 A CN 2010800645209A CN 201080064520 A CN201080064520 A CN 201080064520A CN 102884048 A CN102884048 A CN 102884048A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- pyrimidine
- ethyl
- amine
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C(*)(*)*)=*C(N(*)*)=*C=* Chemical compound CC(C(*)(*)*)=*C(N(*)*)=*C=* 0.000 description 6
- CYFYBRDNQNONOB-CLFYSBASSA-N C/C(/C=C=C)=N/CN=C Chemical compound C/C(/C=C=C)=N/CN=C CYFYBRDNQNONOB-CLFYSBASSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28918209P | 2009-12-22 | 2009-12-22 | |
EP09180321.3 | 2009-12-22 | ||
US61/289182 | 2009-12-22 | ||
EP09180321 | 2009-12-22 | ||
US61/289,182 | 2009-12-22 | ||
PCT/EP2010/070213 WO2011076723A1 (en) | 2009-12-22 | 2010-12-20 | Amino-heteroaryl derivatives as hcn blockers |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102884048A true CN102884048A (zh) | 2013-01-16 |
CN102884048B CN102884048B (zh) | 2014-07-23 |
Family
ID=42045216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080064520.9A Expired - Fee Related CN102884048B (zh) | 2009-12-22 | 2010-12-20 | 用作hcn阻滞剂的氨基杂芳基衍生物 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8952001B2 (zh) |
EP (1) | EP2516397B1 (zh) |
JP (1) | JP5728024B2 (zh) |
KR (1) | KR20120095481A (zh) |
CN (1) | CN102884048B (zh) |
AR (1) | AR079543A1 (zh) |
AU (1) | AU2010335231C1 (zh) |
BR (1) | BR112012015170A8 (zh) |
CA (1) | CA2783209C (zh) |
MX (1) | MX2012007426A (zh) |
RU (1) | RU2549546C2 (zh) |
WO (1) | WO2011076723A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106588803A (zh) * | 2016-11-16 | 2017-04-26 | 西南科技大学 | 一种制备5‑乙酰基异噁唑的新方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012157336A1 (ja) * | 2011-05-19 | 2012-11-22 | 株式会社東芝 | モリブデン造粒粉の製造方法およびモリブデン造粒粉 |
JP5941546B2 (ja) | 2011-09-02 | 2016-06-29 | パーデュー、ファーマ、リミテッド、パートナーシップ | ナトリウムチャネル遮断剤としてのピリミジン |
WO2013072758A1 (en) | 2011-11-15 | 2013-05-23 | Purdue Pharma L.P. | Pyrimidine diol amides as sodium channel blockers |
BR112014028006A2 (pt) | 2012-05-30 | 2017-06-27 | Hoffmann La Roche | heterociclos de pirrolidino |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008067389A2 (en) * | 2006-11-28 | 2008-06-05 | Alsgen, Inc. | Modulation of sod protein synthesis for the treatment of neurodegenerative diseases |
US20090221597A1 (en) * | 2008-02-28 | 2009-09-03 | Sara Hadida Ruah | Heteroaryl derivatives as cftr modulators |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4606757A (en) * | 1982-12-23 | 1986-08-19 | The Dow Chemical Company | Diphenoxymethylpyridines having herbicidal properties |
KR100197583B1 (ko) | 1997-02-04 | 1999-06-15 | 이민화 | 환자용모니터를 구비한 초음파진단장치 |
WO2001090142A2 (en) | 2000-05-24 | 2001-11-29 | Akzo Nobel N.V. | FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS |
CN1237969C (zh) * | 2001-04-10 | 2006-01-25 | 日本新药株式会社 | 慢性关节风湿病的治疗剂 |
US6980419B2 (en) | 2003-03-12 | 2005-12-27 | Zonare Medical Systems, Inc. | Portable ultrasound unit and docking station |
CN101023374A (zh) | 2004-09-17 | 2007-08-22 | 皇家飞利浦电子股份有限公司 | 无线超声系统显示器 |
US8461161B2 (en) * | 2006-11-15 | 2013-06-11 | Ym Biosciences Australia Pty Ltd | Substituted pyrazines as inhibitors of kinase activity |
PE20091524A1 (es) * | 2007-12-19 | 2009-09-25 | Palau Pharma Sa | Derivados de 2-aminopirimidina |
TW201022233A (en) | 2008-11-04 | 2010-06-16 | Organon Nv | (Pyrrolidin-2-yl)phenyl derivatives |
-
2010
- 2010-12-20 EP EP10795690.6A patent/EP2516397B1/en active Active
- 2010-12-20 JP JP2012545268A patent/JP5728024B2/ja not_active Expired - Fee Related
- 2010-12-20 RU RU2012131279/04A patent/RU2549546C2/ru not_active IP Right Cessation
- 2010-12-20 US US13/518,427 patent/US8952001B2/en active Active
- 2010-12-20 MX MX2012007426A patent/MX2012007426A/es active IP Right Grant
- 2010-12-20 CN CN201080064520.9A patent/CN102884048B/zh not_active Expired - Fee Related
- 2010-12-20 AU AU2010335231A patent/AU2010335231C1/en not_active Ceased
- 2010-12-20 AR ARP100104763A patent/AR079543A1/es unknown
- 2010-12-20 CA CA2783209A patent/CA2783209C/en not_active Expired - Fee Related
- 2010-12-20 BR BR112012015170A patent/BR112012015170A8/pt not_active Application Discontinuation
- 2010-12-20 KR KR1020127019218A patent/KR20120095481A/ko not_active Application Discontinuation
- 2010-12-20 WO PCT/EP2010/070213 patent/WO2011076723A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008067389A2 (en) * | 2006-11-28 | 2008-06-05 | Alsgen, Inc. | Modulation of sod protein synthesis for the treatment of neurodegenerative diseases |
US20090221597A1 (en) * | 2008-02-28 | 2009-09-03 | Sara Hadida Ruah | Heteroaryl derivatives as cftr modulators |
Non-Patent Citations (2)
Title |
---|
-: "RN 338397-88-9 REGISTRY", 《STN REGISTRY》, 25 May 2001 (2001-05-25) * |
-: "RN 338976-09-3 REGISTRY", 《STN REGISTRY》, 30 May 2001 (2001-05-30) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106588803A (zh) * | 2016-11-16 | 2017-04-26 | 西南科技大学 | 一种制备5‑乙酰基异噁唑的新方法 |
Also Published As
Publication number | Publication date |
---|---|
AR079543A1 (es) | 2012-02-01 |
EP2516397A1 (en) | 2012-10-31 |
CA2783209A1 (en) | 2011-06-30 |
CA2783209C (en) | 2017-03-14 |
AU2010335231B2 (en) | 2014-09-11 |
AU2010335231C1 (en) | 2015-04-16 |
RU2012131279A (ru) | 2014-01-27 |
BR112012015170A2 (pt) | 2016-03-29 |
US8952001B2 (en) | 2015-02-10 |
JP5728024B2 (ja) | 2015-06-03 |
RU2549546C2 (ru) | 2015-04-27 |
EP2516397B1 (en) | 2016-07-13 |
AU2010335231A1 (en) | 2012-06-21 |
WO2011076723A1 (en) | 2011-06-30 |
MX2012007426A (es) | 2012-07-23 |
JP2013515031A (ja) | 2013-05-02 |
BR112012015170A8 (pt) | 2017-12-26 |
US20120264728A1 (en) | 2012-10-18 |
CN102884048B (zh) | 2014-07-23 |
KR20120095481A (ko) | 2012-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5364872B2 (ja) | 3−ピリジルエナンチオマーおよび鎮痛薬としてのその使用 | |
JP5537085B2 (ja) | アリールビニルアザシクロアルカン化合物およびその調製方法ならびにその使用 | |
EP1491532B1 (en) | Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors | |
CN101861316B (zh) | 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 | |
TW202144340A (zh) | 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用 | |
CN101711236B (zh) | 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物 | |
EP2805940A1 (en) | Pyrazine carboxamide compound | |
CN102884048B (zh) | 用作hcn阻滞剂的氨基杂芳基衍生物 | |
CN101128458A (zh) | 三环δ阿片样物质调节剂 | |
EA014918B1 (ru) | Замещенные бициклические пиримидоновые производные | |
CN102112464A (zh) | 制备四氢异喹啉的方法 | |
CA3012031A1 (en) | 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors | |
JP2023554282A (ja) | 置換ピペリジノ化合物及び関連する治療方法 | |
AU2003243089B2 (en) | Novel compounds, their use and preparation | |
JP2021500416A (ja) | 疼痛及び疼痛関連状態を治療するための新規アルコキシアミノ誘導体 | |
JP2003528098A (ja) | 抗血栓症薬および抗凝血薬としてのn−(ヘテロ環式)ベンゼン−または−ピリジンスルホンアミド | |
JP2018536637A (ja) | 選択的nr2bアンタゴニスト | |
JP2004269547A (ja) | キノキサリンジオン類の製造方法 | |
WO2020021015A1 (en) | New imidazopyridine derivatives for treating pain and pain related conditions | |
TW201130812A (en) | Amino-heteroaryl derivatives | |
WO2024059216A2 (en) | 6,6 southwestern core compounds as mglu5 negative allosteric modulators and methods of making and using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ORGANON BIOSCIENCES NEDERLAND B. V. Free format text: FORMER OWNER: MSD OUSI CO., LTD. Effective date: 20130620 Owner name: MERCK SHARP + DOHME CORP. Free format text: FORMER OWNER: ORGANON BIOSCIENCES NEDERLAND B. V. Effective date: 20130620 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130620 Address after: Haarlem Applicant after: MERCK SHARP & DOHME B.V. Address before: Holland Applicant before: Organic agricultural biological sciences Holland Co.,Ltd. Effective date of registration: 20130620 Address after: Holland Applicant after: Organic agricultural biological sciences Holland Co.,Ltd. Address before: Holland Applicant before: N.V. Organon |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20191220 |
|
CF01 | Termination of patent right due to non-payment of annual fee |